Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Nguyen D.M.,,Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus,2009,Clinical Gastroenterology and Hepatology,112,10.1016/j.cgh.2009.06.001,United States;United States,Article,Houston;Houston,0,Journal,2-s2.0-70849132813
Chung J.W.,,Unchanging trend of esophagogastric junction adenocarcinoma in Korea: Experience at a single institution based on Saiewert's classification,2009,Diseases of the Esophagus,36,10.1111/j.1442-2050.2009.00946.x,South Korea,Article,Ulsan,0,Journal,2-s2.0-75149185564
Lao-Sirieix P.,,Non-endoscopic screening biomarkers for Barrett's oesophagus: From microarray analysis to the clinic,2009,Gut,77,10.1136/gut.2009.180281,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-70350223628
Ampt A.,,"Attitudes, norms and controls influencing lifestyle risk factor management in general practice",2009,BMC Family Practice,118,10.1186/1471-2296-10-59,Australia,Article,Sydney,1,Journal,2-s2.0-70349488693
Brosh R.,,When mutants gain new powers: News from the mutant p53 field,2009,Nature Reviews Cancer,698,10.1038/nrc2693,Israel,Review,Rehovot,0,Journal,2-s2.0-70349443284
Wang J.,,DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in barrett's esophagus,2009,American Journal of Gastroenterology,86,10.1038/ajg.2009.300,United States,Article,Baltimore,0,Journal,2-s2.0-69949111978
Smith K.,,Current and Past Smoking Significantly Increase Risk for Barrett's Esophagus,2009,Clinical Gastroenterology and Hepatology,44,10.1016/j.cgh.2009.04.018,Australia,Article,Brisbane,0,Journal,2-s2.0-67949100668
Steffen A.,,Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition,2009,Cancer Epidemiology Biomarkers and Prevention,92,10.1158/1055-9965.EPI-09-0265,Germany,Article,Nuthetal,1,Journal,2-s2.0-67650541572
Gatenby P.,,Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: A population-based study of natural history,2009,Histopathology,33,10.1111/j.1365-2559.2009.03316.x,United Kingdom,Article,London,0,Journal,2-s2.0-66949144760
Cooper G.,,Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: A population-based study with temporal trends,2009,American Journal of Gastroenterology,97,10.1038/ajg.2009.159,United States;United States,Article,Cleveland;Cleveland,0,Journal,2-s2.0-66949175556
Shaheen N.J.,,Radiofrequency ablation in Barrett's esophagus with dysplasia,2009,New England Journal of Medicine,980,10.1056/NEJMoa0808145,United States;United States,Article,Chapel Hill;Chapel Hill,0,Journal,2-s2.0-66249084112
Paulson T.,,Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma,2009,Clinical Cancer Research,68,10.1158/1078-0432.CCR-08-2494,United States,Article,Seattle,1,Journal,2-s2.0-66149185428
Jin Z.,,"A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus",2009,Cancer Research,146,10.1158/0008-5472.CAN-09-0028,United States,Article,Baltimore,1,Journal,2-s2.0-66249114998
Kissel H.,,Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity,2009,Cancer Biomarkers,9,10.3233/CBM-2009-0618,United States,Article,Seattle,0,Journal,2-s2.0-65449117534
Xing J.,,Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer,2009,Cancer Prevention Research,64,10.1158/1940-6207.CAPR-08-0227,United States,Article,Houston,1,Journal,2-s2.0-67650300515
Kaye P.V.,,"Barrett's dysplasia and the Vienna classification: Reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry",2009,Histopathology,98,10.1111/j.1365-2559.2009.03288.x,United Kingdom;United Kingdom,Article,Nottingham;Nottingham,0,Journal,2-s2.0-65349095555
Elwood P.C.,,"Aspirin, salicylates, and cancer",2009,The Lancet,220,10.1016/S0140-6736(09)60243-9,United Kingdom,Review,Cardiff,0,Journal,2-s2.0-64049106907
Kubo A.,,Cigarette smoking and the risk of Barrett's esophagus,2009,Cancer Causes and Control,42,10.1007/s10552-008-9244-4,United States,Article,Oakland,0,Journal,2-s2.0-61449216998
Mulholland H.G.,,"Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma",2009,Cancer Causes and Control,43,10.1007/s10552-008-9242-6,United Kingdom,Article,Belfast,0,Journal,2-s2.0-61449146129
Edelstein Z.,,Risk factors for barrett's esophagus among patients with gastroesophageal reflux disease: A community clinic-based case-control study,2009,American Journal of Gastroenterology,81,10.1038/ajg.2009.137,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-65449181647
Bloushtain-Qimron N.,,Epigenetic patterns of embryonic and adult stem cells,2009,Cell Cycle,46,10.4161/cc.8.6.7938,Israel;United States,Review,Beer Sheba;Boston,1,Journal,2-s2.0-65349192189
Thompson O.,,Vegetable and fruit intakes and risk of Barrett's esophagus in men and women,2009,American Journal of Clinical Nutrition,31,10.3945/ajcn.2008.26497,United States;United States;United States,Article,Seattle;Bethesda;Seattle,1,Journal,2-s2.0-61449188306
Abnet C.,,Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: Results from a cohort study and a meta-analysis,2009,British Journal of Cancer,133,10.1038/sj.bjc.6604880,United States,Article,Bethesda,1,Journal,2-s2.0-59649106758
Irizarry R.,,The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores,2009,Nature Genetics,1452,10.1038/ng.298,United States;United States,Article,Baltimore;Baltimore,0,Journal,2-s2.0-59149084538
Shar A.O.,,Modeling using baseline characteristics in a small multicenter clinical trial for Barrett's esophagus,2009,Contemporary Clinical Trials,7,10.1016/j.cct.2008.10.001,United States,Article,Princeton,0,Journal,2-s2.0-57549088314
Anderson L.A.,,"The Association Between Alcohol and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma",2009,Gastroenterology,94,10.1053/j.gastro.2008.12.005,United Kingdom,Article,Belfast,0,Journal,2-s2.0-60449099583
Pandeya N.,,Alcohol Consumption and the Risks of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus,2009,Gastroenterology,117,10.1053/j.gastro.2008.12.052,Australia;Australia,Article,Brisbane;Brisbane,0,Journal,2-s2.0-62949198948
Chao D.,,"Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: A long-term prospective study",2008,Clinical Cancer Research,44,10.1158/1078-0432.CCR-07-5063,United States;United States,Article,Seattle;Seattle,1,Journal,2-s2.0-58149231553
Li X.,,"Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in barrett's esophagus neoplastic progression",2008,Cancer Prevention Research,57,10.1158/1940-6207.CAPR-08-0121,United States,Article,Seattle,1,Journal,2-s2.0-61749087820
Rubenstein J.,,Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans,2008,Gastrointestinal Endoscopy,73,10.1016/j.gie.2008.02.062,United States,Article,Ann Arbor,0,Journal,2-s2.0-54449098143
Smith E.,,Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma,2008,Molecular Cancer,48,10.1186/1476-4598-7-75,Australia,Article,Adelaide,1,Journal,2-s2.0-54149111724
Blaser M.J.,,Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma,2008,Cancer Prevention Research,78,10.1158/1940-6207.CAPR-08-0170,United States,Review,New York,1,Journal,2-s2.0-61549127941
Islami F.,,Helicobacter pylori and esophageal cancer risk: A meta-analysis,2008,Cancer Prevention Research,233,10.1158/1940-6207.CAPR-08-0109,France;Iran;United Kingdom,Article,Lyon;Tehran;London,1,Journal,2-s2.0-57249113908
Zagari R.,,"Gastro-oesophageal reflux symptoms, oesophagitis and barrett's oesophagus in the general population: The Loiano-Monghidoro study",2008,Gut,261,10.1136/gut.2007.145177,Italy,Article,Bologna,0,Journal,2-s2.0-50849138325
Lao-sirieix P.,,Physiological and molecular analysis of acid loading mechanisms in squamous and columnar-lined esophagus,2008,Diseases of the Esophagus,17,10.1111/j.1442-2050.2007.00807.x,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-51249115618
Khoury M.,,A decade of public health genomics in the united states: Centers for disease control and prevention 1997-2007,2008,Public Health Genomics,24,10.1159/000153427,United States,Review,Atlanta,1,Journal,2-s2.0-68149132313
Jenkins G.J.S.,,"The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-κB activation in oesophageal cells, with a mechanism of action involving ROS",2008,Mutagenesis,57,10.1093/mutage/gen029,United Kingdom,Article,Swansea,1,Journal,2-s2.0-50849088985
Rakyan V.,,An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs),2008,Genome Research,297,10.1101/gr.077479.108,United Kingdom,Article,London,1,Journal,2-s2.0-50649108994
Haibe-Kains B.,,Comparison of prognostic gene expression signatures for breast cancer,2008,BMC Genomics,110,10.1186/1471-2164-9-394,Belgium;Belgium,Article,Brussels;Brussels,1,Journal,2-s2.0-51349107911
Shibata A.,,"Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001",2008,Japanese Journal of Clinical Oncology,94,10.1093/jjco/hyn064,Japan,Article,Yamagata,1,Journal,2-s2.0-48849102021
Munitiz V.,,High risk of malignancy in familial barrett's esophagus: Presentation of one family,2008,Journal of Clinical Gastroenterology,17,10.1097/MCG.0b013e3180329015,Spain,Article,Murcia,0,Journal,2-s2.0-53749097657
Barr Fritcher E.,,"A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus",2008,Human Pathology,53,10.1016/j.humpath.2008.02.003,United States,Article,Rochester,0,Journal,2-s2.0-47549114817
Hursting S.,,Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link,2008,Best Practice and Research: Clinical Endocrinology and Metabolism,79,10.1016/j.beem.2008.08.009,,Review,,0,Journal,2-s2.0-54849433477
Leedham S.J.,,Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus,2008,Gut,149,10.1136/gut.2007.143339,United Kingdom,Article,London,1,Journal,2-s2.0-48249128273
Yousef F.,,The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: A systematic review and meta-analysis,2008,American Journal of Epidemiology,268,10.1093/aje/kwn121,United Kingdom,Review,Belfast,1,Journal,2-s2.0-47649099118
Brown L.M.,,"Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age",2008,Journal of the National Cancer Institute,504,10.1093/jnci/djn211,United States;United States,Article,Research Triangle Park;Bethesda,1,Journal,2-s2.0-51049091878
Haghdoost A.A.,,"Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran",2008,Archives of Iranian Medicine,24,,Iran,Article,Kerman,0,Journal,2-s2.0-48449106917
Doecke J.,,Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma,2008,International Journal of Cancer,65,10.1002/ijc.23410,Australia,Article,Brisbane,1,Journal,2-s2.0-42149190878
Kubo A.,,"Dietary antioxidants, fruits, and vegetables and the risk of barrett's esophagus",2008,American Journal of Gastroenterology,68,10.1111/j.1572-0241.2008.01838.x,United States,Article,Oakland,0,Journal,2-s2.0-50649085028
Nancarrow D.,,Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays,2008,Cancer Research,71,10.1158/0008-5472.CAN-07-6710,Australia,Article,Brisbane,1,Journal,2-s2.0-49249119361
Sadeghi S.,,"Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus",2008,Cancer Epidemiology Biomarkers and Prevention,62,10.1158/1055-9965.EPI-07-2852,Australia,Article,Brisbane,1,Journal,2-s2.0-52649086351
Das D.,,Management of Barrett's esophagus in the UK: Overtreated and underbiopsied but improved by the introduction of a national randomized trial,2008,American Journal of Gastroenterology,71,10.1111/j.1572-0241.2008.01790.x,United Kingdom,Article,Leicester,0,Journal,2-s2.0-43549110733
Kendall B.J.,,Leptin and the risk of Barrett's oesophagus,2008,Gut,105,10.1136/gut.2007.131243,Australia,Article,Brisbane,0,Journal,2-s2.0-41149088116
Peng D.F.,,Alterations in Barrett's-related adenocarcinomas: A proteomic approach,2008,International Journal of Cancer,28,10.1002/ijc.23258,United States,Article,Nashville,1,Journal,2-s2.0-39649094503
Ferguson H.R.,,"Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma",2008,Cancer Epidemiology Biomarkers and Prevention,39,10.1158/1055-9965.EPI-07-2570,United Kingdom,Article,Belfast,1,Journal,2-s2.0-41549164836
Wang K.,,"Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus",2008,American Journal of Gastroenterology,915,10.1111/j.1572-0241.2008.01835.x,,Review,,0,Journal,2-s2.0-40949156279
Van Baal J.,,A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma,2008,Cellular Oncology,24,,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-38549157014
Moayyedi P.,,Mortality rates in patients with Barrett's oesophagus,2008,Alimentary Pharmacology and Therapeutics,71,10.1111/j.1365-2036.2007.03582.x,Canada;United Kingdom,Article,Hamilton;Leicester,1,Journal,2-s2.0-38149000716
Corley D.,,Abdominal obesity and the risk of esophageal and gastric cardia carcinomas,2008,Cancer Epidemiology Biomarkers and Prevention,152,10.1158/1055-9965.EPI-07-0748,United States;United States,Article,San Francisco;Oakland,1,Journal,2-s2.0-39449136419
Whiteman D.C.,,"Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus",2008,Gut,227,10.1136/gut.2007.131375,Australia;Australia,Article,Brisbane;Brisbane,1,Journal,2-s2.0-38549141804
Duan L.,,Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County,2008,Cancer Epidemiology Biomarkers and Prevention,46,10.1158/1055-9965.EPI-07-0664,United States;United States,Article,Los Angeles;Los Angeles,1,Journal,2-s2.0-38849157724
Dumur C.I.,,Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers,2008,Journal of Molecular Diagnostics,76,10.2353/jmoldx.2008.070099,United States,Article,Richmond,0,Journal,2-s2.0-38749130138
Wu J.,,Gastroesophageal reflux disease: An Asian perspective,2008,Journal of Gastroenterology and Hepatology (Australia),82,10.1111/j.1440-1746.2008.05684.x,Hong Kong;Hong Kong,Review,;Shatin,1,Journal,2-s2.0-57049161854
Pouw R.,,"Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection",2008,Journal of Gastrointestinal Surgery,108,10.1007/s11605-008-0629-1,Netherlands,Conference Paper,Amsterdam,1,Journal,2-s2.0-52549087531
Kahrilas P.,,American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease,2008,Gastroenterology,294,10.1053/j.gastro.2008.08.044,United States,Article,Chicago,0,Journal,2-s2.0-53049093728
Yuk K.,,Decreasing trend of esophageal adenocarcinoma in Hong Kong,2007,Cancer Epidemiology Biomarkers and Prevention,43,10.1158/1055-9965.EPI-07-0421,Hong Kong,Article,Pokfulam,1,Journal,2-s2.0-38849178043
Jovov B.,,Claudin-18: A dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance,2007,American Journal of Physiology - Gastrointestinal and Liver Physiology,92,10.1152/ajpgi.00158.2007,United States,Article,Chapel Hill,0,Journal,2-s2.0-37149051637
Risques R.A.,,Leukocyte telomere length predicts cancer risk in Barrett's esophagus,2007,Cancer Epidemiology Biomarkers and Prevention,121,10.1158/1055-9965.EPI-07-0624,United States,Article,Seattle,1,Journal,2-s2.0-38949140844
Thomas T.,,Meta analysis: Cancer risk in Barrett's oesophagus,2007,Alimentary Pharmacology and Therapeutics,121,10.1111/j.1365-2036.2007.03528.x,United Kingdom,Article,Leicester,1,Journal,2-s2.0-36549033910
Terry M.,,Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas,2007,Cancer Causes and Control,26,10.1007/s10552-007-9046-0,United States,Article,New York,0,Journal,2-s2.0-34547794183
Moons L.,,COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma,2007,American Journal of Gastroenterology,39,10.1111/j.1572-0241.2007.01373.x,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-35448943037
Orlando R.,,Mucosal Defense in Barrett's Esophagus,2007,Barrett's Esophagus and Esophageal Adenocarcinoma: Second Edition,24,10.1002/9780470987513.ch7,United States,Chapter,New Orleans,0,Book,2-s2.0-84889456619
Hiyama T.,,Genetic polymorphisms and esophageal cancer risk,2007,International Journal of Cancer,180,10.1002/ijc.23044,Japan,Short Survey,Higashihiroshima,1,Journal,2-s2.0-34548669838
Cook M.B.,,Risk of mortality and cancer incidence in Barrett's esophagus,2007,Cancer Epidemiology Biomarkers and Prevention,57,10.1158/1055-9965.EPI-07-0432,United Kingdom,Article,Leeds,1,Journal,2-s2.0-35448994309
Wu A.H.,,Fiber intake and risk of adenocarcinomas of the esophagus and stomach,2007,Cancer Causes and Control,52,10.1007/s10552-007-9014-8,United States,Article,Los Angeles,0,Journal,2-s2.0-34250862092
Overholt B.,,Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia,2007,Gastrointestinal Endoscopy,284,10.1016/j.gie.2006.12.037,United States,Article,Knoxville,0,Journal,2-s2.0-34548108585
Wideroff L.,,"GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas",2007,Cancer Detection and Prevention,63,10.1016/j.cdp.2007.03.004,United States,Article,Bethesda,0,Journal,2-s2.0-34547895867
Tobey N.,,Electrical parameters and ion species for active transport in human esophageal stratified squamous epithelium and Barrett's specialized columnar epithelium,2007,American Journal of Physiology - Gastrointestinal and Liver Physiology,41,10.1152/ajpgi.00047.2007,United States,Article,New Orleans,0,Journal,2-s2.0-34547110590
Ostrowski J.,,Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics,2007,Journal of Molecular Medicine,41,10.1007/s00109-007-0176-3,Poland,Article,Warsaw,0,Journal,2-s2.0-34447328450
Zhao J.,,Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping,2007,Molecular and Cellular Proteomics,27,10.1074/mcp.M600175-MCP200,United States,Article,Ann Arbor,1,Journal,2-s2.0-34347372593
Di Martino E.,,The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma,2007,Genetics in Medicine,41,10.1097/GIM.0b013e3180654ccd,United Kingdom,Article,Leeds,1,Journal,2-s2.0-34250706801
Murphy S.,,A population-based association study of SNPs of GSTP1 MnSOD GPX2 and Barrett's esophagus and esophageal adenocarcinoma,2007,Carcinogenesis,45,10.1093/carcin/bgm007,United Kingdom,Article,Belfast,1,Journal,2-s2.0-34447296712
Lai L.,,Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH,2007,Genes Chromosomes and Cancer,65,10.1002/gcc.20435,United States,Article,Seattle,0,Journal,2-s2.0-34247476112
Heath E.I.,,Secondary chemoprevention of Barrett's esophagus with celecoxib: Results of a randomized trial,2007,Journal of the National Cancer Institute,134,10.1093/jnci/djk112,United States,Article,Detroit,1,Journal,2-s2.0-34247633538
Anderson L.,,Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study,2007,World Journal of Gastroenterology,179,10.3748/wjg.v13.i10.1585,United Kingdom,Article,Belfast,0,Journal,2-s2.0-34247613923
Srivastava A.,,Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus,2007,American Journal of Gastroenterology,90,10.1111/j.1572-0241.2007.01073.x,United States,Article,Boston,0,Journal,2-s2.0-33847266287
Galipeau P.,,"NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma",2007,PLoS Medicine,189,10.1371/journal.pmed.0040067,United States,Article,Seattle,1,Journal,2-s2.0-33847617509
Ochs-Balcom H.M.,,Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma,2007,Translational Research,12,10.1016/j.trsl.2007.02.005,United States;United States,Article,Cleveland;Cleveland,0,Journal,2-s2.0-34250788489
Mörk H.,,High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation,2007,Scandinavian Journal of Gastroenterology,35,10.1080/00365520600825125,Germany,Article,,0,Journal,2-s2.0-33845917255
Feagins L.,,Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells,2007,American Journal of Gastroenterology,46,10.1111/j.1572-0241.2006.01005.x,United States,Article,Dallas,0,Journal,2-s2.0-33846079689
Edelstein Z.,,Central Adiposity and Risk of Barrett's Esophagus,2007,Gastroenterology,227,10.1053/j.gastro.2007.05.026,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-34547518829
Corley D.,,Abdominal Obesity and Body Mass Index as Risk Factors for Barrett's Esophagus,2007,Gastroenterology,265,10.1053/j.gastro.2007.04.046,United States;United States,Article,San Francisco;Oakland,0,Journal,2-s2.0-34447097514
Holmes R.,,Epidemiology and Pathogenesis of Esophageal Cancer,2007,Seminars in Radiation Oncology,428,10.1016/j.semradonc.2006.09.003,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-33845485257
Dollman J.,,Secular changes in fatness and fat distribution in Australian children matched for body size,2006,International Journal of Pediatric Obesity,24,10.1080/17477160600684260,Australia,Article,Adelaide,0,Journal,2-s2.0-35148885072
Fitzgerald R.,,Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma,2006,Gut,106,10.1136/gut.2005.089144,United Kingdom,Review,Cambridge,0,Journal,2-s2.0-33845380456
Di Martino E.,,IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: Potential biomarkers of disease risk,2006,Biomarkers,35,10.1080/13547500600896791,United Kingdom,Article,Leeds,0,Journal,2-s2.0-33750366123
Corley D.,,Body mass index and gastroesophageal reflux disease: A systematic review and meta-analysis,2006,American Journal of Gastroenterology,217,10.1111/j.1572-0241.2006.00849.x,United States;United States,Review,San Francisco;Oakland,0,Journal,2-s2.0-33750528401
Chao D.,,Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: A prospective analysis,2006,Cancer Epidemiology Biomarkers and Prevention,29,10.1158/1055-9965.EPI-06-0492,United States,Article,Seattle,1,Journal,2-s2.0-33750523998
Murray L.,,TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort,2006,Gut,97,10.1136/gut.2005.083295,United Kingdom,Article,Belfast,0,Journal,2-s2.0-33749167729
Jeon J.,,Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States),2006,Cancer Causes and Control,53,10.1007/s10552-006-0037-3,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-33746065267
Kraly J.,,Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues,2006,Analytical Chemistry,75,10.1021/ac061029+,United States,Article,Seattle,0,Journal,2-s2.0-33748479469
Ye W.,,The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: A population-based case-control study in Sweden,2006,Carcinogenesis,74,10.1093/carcin/bgl017,Sweden,Article,Stockholm,1,Journal,2-s2.0-33747879885
Chak A.,,"Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction",2006,Cancer Epidemiology Biomarkers and Prevention,79,10.1158/1055-9965.EPI-06-0293,United States,Review,Cleveland,1,Journal,2-s2.0-33749366481
Samanic C.,,"Relation of body mass index to cancer risk in 362,552 Swedish men",2006,Cancer Causes and Control,279,10.1007/s10552-006-0023-9,United States,Article,Bethesda,0,Journal,2-s2.0-33746089143
El-Serag H.,,Anthropometric correlates of intragastric pressure,2006,Scandinavian Journal of Gastroenterology,100,10.1080/00365520500535402,United States;United States,Article,Houston;Houston,0,Journal,2-s2.0-33745726797
Demissie S.,,"Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study",2006,Aging Cell,367,10.1111/j.1474-9726.2006.00224.x,United States,Article,Boston,1,Journal,2-s2.0-33746316181
Vakil N.,,The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus,2006,American Journal of Gastroenterology,2232,10.1111/j.1572-0241.2006.00630.x,United States;United States;United States,Review,Madison;Milwaukee;Milwaukee,0,Journal,2-s2.0-33746709974
Fernandes M.L.,,Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic Asian country,2006,American Journal of Gastroenterology,71,10.1111/j.1572-0241.2006.00570.x,Singapore,Article,Singapore City,0,Journal,2-s2.0-33745547698
Jankowski J.,,Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base [11],2006,British Medical Journal,42,,United Kingdom,Letter,Oxford,0,Journal,2-s2.0-33745685183
Kelloff G.,,Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer - A plan to move forward,2006,Clinical Cancer Research,231,10.1158/1078-0432.CCR-06-1104,United States,Review,Bethesda,1,Journal,2-s2.0-33745683516
Marcus P.,,Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis,2006,Journal of the National Cancer Institute,156,10.1093/jnci/djj207,United States,Article,Bethesda,1,Journal,2-s2.0-33745246057
MacInnis R.,,Body size and composition and the risk of gastric and oesophageal adenocarcinoma,2006,International Journal of Cancer,85,10.1002/ijc.21638,Australia;Australia,Article,Parkville;Melbourne,0,Journal,2-s2.0-33646405477
Anderson L.,,Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma Sequence,2006,Cancer Research,99,10.1158/0008-5472.CAN-05-4253,United Kingdom,Article,Belfast,1,Journal,2-s2.0-33646436171
Kubo A.,,Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and meta-analysis,2006,Cancer Epidemiology Biomarkers and Prevention,310,10.1158/1055-9965.EPI-05-0860,United States;United States,Review,New York;Oakland,1,Journal,2-s2.0-33744732468
Sharma P.,,Dysplasia and Cancer in a Large Multicenter Cohort of Patients With Barrett's Esophagus,2006,Clinical Gastroenterology and Hepatology,327,10.1016/j.cgh.2006.03.001,United States,Article,,0,Journal,2-s2.0-33745608781
Ogden C.,,"Prevalence of overweight and obesity in the United States, 1999-2004",2006,Journal of the American Medical Association,7086,10.1001/jama.295.13.1549,United States,Article,Hyattsville,1,Journal,2-s2.0-33645523067
Maley C.,,Genetic clonal diversity predicts progression to esophageal adenocarcinoma,2006,Nature Genetics,496,10.1038/ng1768,United States,Article,Philadelphia,0,Journal,2-s2.0-33645396945
Cooper B.T.,,Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: Observations on regression and cancer incidence,2006,Alimentary Pharmacology and Therapeutics,94,10.1111/j.1365-2036.2006.02825.x,United Kingdom,Article,Birmingham,1,Journal,2-s2.0-33644781586
Trayhurn P.,,Adipose tissue and adipokines - Energy regulation from the human perspective,2006,Journal of Nutrition,167,10.1093/jn/136.7.1935s,United Kingdom,Conference Paper,Liverpool,1,Journal,2-s2.0-33745646751
Hirota W.,,ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract,2006,Gastrointestinal Endoscopy,387,10.1016/j.gie.2006.02.004,,Article,,0,Journal,2-s2.0-33645240406
Chawla S.,,The natural history of observed enhancing renal masses: Meta-analysis and review of the world literature,2006,Journal of Urology,558,10.1016/S0022-5347(05)00148-5,United States,Article,Philadelphia,0,Journal,2-s2.0-30344458234
Solaymani-Dodaran M.,,Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses - A population-based cohort study,2005,American Journal of Gastroenterology,55,10.1111/j.1572-0241.2005.00340.x,United Kingdom,Article,Nottingham,0,Journal,2-s2.0-33644816341
Vaughan T.,,Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: A prospective study,2005,Lancet Oncology,172,10.1016/S1470-2045(05)70431-9,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-28044459843
El-Serag H.,,Abdominal obesity and the risk of Barrett's esophagus,2005,American Journal of Gastroenterology,174,10.1111/j.1572-0241.2005.00251.x,United States;United States,Article,Houston;Houston,0,Journal,2-s2.0-27744517058
Overholt B.,,"Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: International, partially blinded, randomized phase III trial",2005,Gastrointestinal Endoscopy,427,10.1016/j.gie.2005.06.047,United States,Article,Knoxville,0,Journal,2-s2.0-25644437229
Groves C.,,A family history of Barrett's oesophagus: Another risk factor?,2005,Scandinavian Journal of Gastroenterology,15,10.1080/00365520510023189,United Kingdom;United Kingdom,Article,Uxbridge;Uxbridge,0,Journal,2-s2.0-24744446415
Casson A.,,Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma,2005,Carcinogenesis,80,10.1093/carcin/bgi115,Canada,Article,Halifax,1,Journal,2-s2.0-24144476305
Valdes A.M.,,"Obesity, cigarette smoking, and telomere length in women",2005,Lancet,962,10.1016/S0140-6736(05)66630-5,United Kingdom,Article,London,0,Journal,2-s2.0-23844517498
Hampel H.,,Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications,2005,Annals of Internal Medicine,797,10.7326/0003-4819-143-3-200508020-00006,United States,Review,Houston,0,Journal,2-s2.0-23044493202
Fitzgerald R.,,"Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma",2005,Clinical Gastroenterology and Hepatology,21,10.1016/S1542-3565(05)00248-X,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-20444459756
Albertsen P.,,20-Year outcomes following conservative management of clinically localized prostate cancer,2005,Journal of the American Medical Association,945,10.1001/jama.293.17.2095,United States,Article,Farmington,1,Journal,2-s2.0-17844402699
Helm J.,,Dedifferentiation precedes invasion in the progression from barrett's metaplasia to esophageal adenocarcinoma,2005,Clinical Cancer Research,47,10.1158/1078-0432.CCR-04-1280,United States,Article,Tampa,1,Journal,2-s2.0-17644416753
Dulai G.,,Dysplasia and risk of further neoplastic progression in a regional veterans administration Barrett's cohort,2005,American Journal of Gastroenterology,84,10.1111/j.1572-0241.2005.41300.x,United States,Article,,0,Journal,2-s2.0-17544377741
Lindblad M.,,"Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study",2005,Cancer Causes and Control,210,10.1007/s10552-004-3485-7,Sweden,Article,Stockholm,0,Journal,2-s2.0-21244474867
De Martel C.,,Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma,2005,Journal of Infectious Diseases,94,10.1086/427659,United States,Article,Stanford,1,Journal,2-s2.0-13944249442
Breivik J.,,The evolutionary origin of genetic instability in cancer development,2005,Seminars in Cancer Biology,75,10.1016/j.semcancer.2004.09.008,Norway;Norway,Review,Oslo;Oslo,0,Journal,2-s2.0-10944254814
Kim J.,,Prevalence of Barrett's esophagus in Korea,2005,Journal of Gastroenterology and Hepatology (Australia),32,10.1111/j.1440-1746.2005.03749.x,South Korea,Article,Seoul,0,Journal,2-s2.0-19944416897
Lim S.,,Changing prevalence of gastroesophageal reflux with changing time: Longitudinal study in an Asian population,2005,Journal of Gastroenterology and Hepatology (Australia),62,10.1111/j.1440-1746.2005.03887.x,Singapore,Article,Singapore City,0,Journal,2-s2.0-20444466168
Van Baal J.,,"A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia",2005,Gastroenterology,70,10.1053/j.gastro.2005.07.026,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-26844542497
Barlow W.,,The pathogenesis of heartburn in nonerosive reflux disease: A unifying hypothesis,2005,Gastroenterology,208,10.1053/j.gastro.2004.08.014,United States,Article,New Orleans,0,Journal,2-s2.0-15744396335
Ronkainen J.,,Prevalence of Barrett's esophagus in the general population: An endoscopic study,2005,Gastroenterology,670,10.1053/j.gastro.2005.08.053,Sweden;Finland,Article,Stockholm;Ikaalinen,0,Journal,2-s2.0-28844461009
Hage M.,,Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years,2004,Scandinavian Journal of Gastroenterology,99,10.1080/00365520410003524,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-10644232857
Chak A.,,Identification of Barrett's esophagus in relatives by endoscopic screening,2004,American Journal of Gastroenterology,48,10.1111/j.1572-0241.2004.40464.x,United States,Article,Cleveland,0,Journal,2-s2.0-8744309168
Maley C.,,The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma,2004,Cancer Research,146,10.1158/0008-5472.CAN-04-1738,United States,Article,Seattle,1,Journal,2-s2.0-5644255657
Engeland A.,,Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women,2004,Cancer Causes and Control,67,10.1023/B:CACO.0000043434.21558.ea,Norway,Article,Oslo,0,Journal,2-s2.0-5044222782
Fountoulakis A.,,Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer,2004,British Journal of Surgery,117,10.1002/bjs.4591,United Kingdom,Article,Leeds,0,Journal,2-s2.0-4043109112
Paulson T.,,Focus on Barrett's esophagus and esophageal adenocarcinoma,2004,Cancer Cell,96,10.1016/j.ccr.2004.06.021,United States;United States,Review,Seattle;Seattle,1,Journal,2-s2.0-3142619409
Maley C.,,Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus,2004,Cancer Research,169,10.1158/0008-5472.CAN-03-3249,United States;United States,Article,Seattle;Seattle,1,Journal,2-s2.0-2442649306
Folkman J.,,Cancer without disease,2004,Nature,396,10.1038/427787a,United States,Review,Boston,0,Journal,2-s2.0-1542319129
Sharma P.,,A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chicago Workshop,2004,Gastroenterology,456,10.1053/j.gastro.2004.04.010,United States,Conference Paper,Kansas City,0,Journal,2-s2.0-3242658404
Calle E.,,"Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms",2004,Nature Reviews Cancer,2366,10.1038/nrc1408,United States,Review,Atlanta,0,Journal,2-s2.0-3543072186
Engel L.,,Population attributable risks of esophageal and gastric cancers,2003,Journal of the National Cancer Institute,499,10.1093/jnci/djg047,United States;United States,Article,Bethesda;New York,0,Journal,2-s2.0-0141506127
Drovdlic C.M.,,Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma,2003,Journal of Medical Genetics,34,10.1136/jmg.40.9.651,United States;United States;United States,Article,Columbus;Columbus;Leuven,1,Journal,2-s2.0-0042329962
Wu A.,,"Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma",2003,Cancer,151,10.1002/cncr.11568,United States;United States,Article,Los Angeles;Los Angeles,0,Journal,2-s2.0-0041386299
Conio M.,,Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: A prospective study,2003,American Journal of Gastroenterology,203,10.1111/j.1572-0241.2003.07666.x,Italy,Article,Genova,0,Journal,2-s2.0-0141845135
Anderson L.,,Mortality in Barrett's oesophagus: Results from a population based study,2003,Gut,135,10.1136/gut.52.8.1081,United Kingdom,Article,Belfast,1,Journal,2-s2.0-0038637416
Mohammed I.,,Genetic influences in gastro-oesophageal reflux disease: A twin study,2003,Gut,193,10.1136/gut.52.8.1085,United Kingdom,Article,West Bromwich,1,Journal,2-s2.0-0038298411
Sirieix P.,,Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus,2003,Clinical Cancer Research,75,,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-0037479835
Polednak A.,,"Trends in survival for both histologic types of esophageal cancer in U.S. Surveillance, Epidemiology and End Results areas",2003,International Journal of Cancer,129,10.1002/ijc.11029,United States,Article,Hartford,0,Journal,2-s2.0-0037457655
El-Omar E.,,Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms,2003,Gastroenterology,738,10.1016/S0016-5085(03)00157-4,United Kingdom;United States;United Kingdom,Article,Aberdeen;Bethesda;Aberdeen,0,Journal,2-s2.0-0037622073
Rajagopalan H.,,The significance of unstable chromosomes in colorectal cancer,2003,Nature Reviews Cancer,389,10.1038/nrc1165,United States,Review,Baltimore,0,Journal,2-s2.0-0141576687
Corley D.,,Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis,2003,Gastroenterology,433,10.1053/gast.2003.50008,United States,Article,San Francisco,0,Journal,2-s2.0-0037219463
Sihvo E.,,Oxidative stress has a role in malignant transformation in Barrett's oesophagus,2002,International Journal of Cancer,80,10.1002/ijc.10755,Finland,Article,Helsinki,1,Journal,2-s2.0-0037146760
Chak A.,,"Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults",2002,Gut,153,10.1136/gut.51.3.323,United States,Article,Cleveland,1,Journal,2-s2.0-0036717903
Vaughan T.,,"Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus",2002,Cancer Epidemiology Biomarkers and Prevention,85,,United States,Article,Seattle,0,Journal,2-s2.0-0036323531
Jenkins G.J.S.,,Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma,2002,British Journal of Surgery,103,10.1046/j.1365-2168.2002.02107.x,United Kingdom,Review,Swansea,0,Journal,2-s2.0-0036066913
Von Zglinicki T.,,Oxidative stress shortens telomeres,2002,Trends in Biochemical Sciences,1492,10.1016/S0968-0004(02)02110-2,United Kingdom,Review,Newcastle,0,Journal,2-s2.0-0036629255
Shaheen N.,,"Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Scientific review",2002,Journal of the American Medical Association,363,10.1001/jama.287.15.1972,United States,Review,Chapel Hill,1,Journal,2-s2.0-0037123274
Barrett M.,,Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae,2002,Neoplasia,41,10.1038/sj/neo/7900221,United States,Article,Seattle,0,Journal,2-s2.0-0036122474
Incarbone R.,,Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus,2002,Surgical Endoscopy and Other Interventional Techniques,86,10.1007/s00464-001-8161-3,Italy,Article,Milan,0,Journal,2-s2.0-0036151675
Ferguson M.,,Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients,2002,Journal of Gastrointestinal Surgery,70,10.1016/S1091-255X(01)00052-X,United States,Article,Chicago,0,Journal,2-s2.0-15944368199
Cameron A.,,Gastroesophageal reflux disease in monozygotic and dizygotic twins,2002,Gastroenterology,195,10.1053/gast.2002.30301,United States,Article,Rochester,0,Journal,2-s2.0-0036140724
Dulai G.,,Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review,2002,Gastroenterology,267,10.1053/gast.2002.30297,United States,Article,Los Angeles,0,Journal,2-s2.0-0036143976
Buttar N.S.,,Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus,2002,Gastroenterology,326,10.1053/gast.2002.32371,United States,Article,Rochester,0,Journal,2-s2.0-0036204834
Corley D.A.,,Surveillance and survival in Barrett's adenocarcinomas: A population-based study,2002,Gastroenterology,417,10.1053/gast.2002.31879,United States;United States,Article,Berkeley;San Francisco,0,Journal,2-s2.0-0036179390
Dixon J.,,Esophageal mucin: An adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett's esophagus,2001,American Journal of Gastroenterology,53,10.1016/S0002-9270(01)02721-6,,Article,,0,Journal,2-s2.0-0034827893
Wu A.,,"A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States)",2001,Cancer Causes and Control,253,10.1023/A:1011290704728,United States,Article,Los Angeles,0,Journal,2-s2.0-0034871494
Bollschweiler E.,,Demographic variations in the rising incidence of esophageal adenocarcinoma in white males,2001,Cancer,385,10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L,Germany,Article,Koln,1,Journal,2-s2.0-0035423905
Conio M.,,"Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota",2001,Gut,216,10.1136/gut.48.3.304,United States,Article,Rochester,1,Journal,2-s2.0-0035059984
Wijnhoven B.,,Molecular biology of Barrett's adenocarcinoma,2001,Annals of Surgery,93,10.1097/00000658-200103000-00005,Netherlands,Review,Rotterdam,0,Journal,2-s2.0-0035116072
Weston A.,,p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: Immunohistochemical marker predictive of progression,2001,American Journal of Gastroenterology,182,10.1016/S0002-9270(01)02414-5,United States;United States,Article,;Kansas City,0,Journal,2-s2.0-0035007905
Mayne S.T.,,Nutrient intake and risk of subtypes of esophageal and gastric cancer,2001,Cancer Epidemiology Biomarkers and Prevention,361,,United States,Article,New Haven,0,Journal,2-s2.0-0034788391
Buttar N.,,Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma,2001,Gastroenterology,377,10.1053/gast.2001.25111,United States,Article,Rochester,0,Journal,2-s2.0-0035022127
Schnell T.,,Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia,2001,Gastroenterology,521,10.1053/gast.2001.25065,United States;United States,Article,Maywood;,0,Journal,2-s2.0-0034995578
Montgomery E.,,Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation,2001,Human Pathology,629,10.1053/hupa.2001.23510,United States,Article,Baltimore,0,Journal,2-s2.0-0035028767
Ofman J.J.,,The economic impact of the diagnosis of dysplasia in Barrett's esophagus,2000,American Journal of Gastroenterology,28,10.1016/S0002-9270(00)02002-5,United States,Article,Beverly Hills,0,Journal,2-s2.0-0033784968
Bani-Hani K.,,Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma,2000,Journal of the National Cancer Institute,204,10.1093/jnci/92.16.1316,United Kingdom,Article,Leeds,1,Journal,2-s2.0-0034674912
Reid B.,,Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets,2000,American Journal of Gastroenterology,570,10.1016/S0002-9270(00)00988-6,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-0033915683
Farrow D.C.,,"Gastroesophageal reflux disease, use of H<inf>2</inf> receptor antagonists, and risk of esophageal and gastric cancer",2000,Cancer Causes and Control,191,10.1023/A:1008913828105,United States;United States,Note,Seattle;Seattle,0,Journal,2-s2.0-0034068341
Grisham M.,,Chronic inflammation and reactive oxygen and nitrogen metabolism - Implications in DNA damage and mutagenesis,2000,"Alimentary Pharmacology and Therapeutics, Supplement",92,,United States,Conference Paper,Shreveport,0,Journal,2-s2.0-0034031811
Barrett M.,,Evolution of neoplastic cell lineages in Barrett oesophagus,1999,Nature Genetics,365,10.1038/8816,United States,Article,Stanford,0,Journal,2-s2.0-0032953491
Turker M.,,A novel signature mutation for oxidative damage resembles a mutational pattern found commonly in human cancers,1999,Cancer Research,62,,United States,Article,Portland,0,Journal,2-s2.0-0033561526
Lagergren J.,,Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma,1999,New England Journal of Medicine,2442,10.1056/NEJM199903183401101,Sweden;Sweden,Article,Stockholm;Stockholm,0,Journal,2-s2.0-0033580405
Bytzer P.,,Adenocarcinoma of the esophagus and Barrett's esophagus: A population- based study,1999,American Journal of Gastroenterology,247,10.1111/j.1572-0241.1999.00776.x,Denmark,Article,Odense,0,Journal,2-s2.0-0032893795
Ouatu-Lascar R.,,Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression,1999,Gastroenterology,332,10.1053/gast.1999.0029900327,United States,Article,Palo Alto,0,Journal,2-s2.0-0032782622
Sampliner R.,,"Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus",1998,American Journal of Gastroenterology,614,10.1111/j.1572-0241.1998.00362.x,United States;United States,Review,Tucson;Tucson,0,Journal,2-s2.0-0032467590
Chow W.H.,,An inverse relation between cagA<sup>+</sup> strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma,1998,Cancer Research,465,,United States,Article,Bethesda,0,Journal,2-s2.0-17144440127
Farrow D.,,Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer,1998,Cancer Epidemiology Biomarkers and Prevention,422,,United States,Article,Seattle,0,Journal,2-s2.0-6844240876
Chow W.H.,,Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia,1998,Journal of the National Cancer Institute,515,10.1093/jnci/90.2.150,United States;United States,Article,Bethesda;Bethesda,1,Journal,2-s2.0-17944386992
Van Sandick J.,,Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma,1998,Gut,362,10.1136/gut.43.2.216,Netherlands,Article,Amsterdam,1,Journal,2-s2.0-0031855413
Gammon M.D.,,"Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia",1997,Journal of the National Cancer Institute,495,10.1093/jnci/89.17.1277,United States,Article,New York,1,Journal,2-s2.0-0030777204
Cameron A.,,"Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: A pathological study",1997,American Journal of Gastroenterology,273,,United States,Article,Rochester,0,Journal,2-s2.0-0030933230
Macdonald C.,,Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital,1997,Gut,45,10.1136/gut.41.3.303,United Kingdom,Article,Leicester,1,Journal,2-s2.0-0030882179
Romero Y.,,Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma,1997,Gastroenterology,202,10.1053/gast.1997.v113.pm9352846,United States,Article,Rochester,0,Journal,2-s2.0-0030730876
Poynton A.,,Carcinoma arising in familial Barrett's esophagus,1996,American Journal of Gastroenterology,40,,Ireland,Article,Dublin,0,Journal,2-s2.0-0029817850
Vaughan T.,,"Obesity, Alcohol, and Tobacco as Risk Factors for Cancers of the Esophagus and Gastric Cardia: Adenocarcinoma Versus Squamous Cell Carcinoma",1995,Cancer Epidemiology Biomarkers and Prevention,432,,United States,Article,Seattle,0,Journal,2-s2.0-0028946573
Fleming T.,,"Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and aids research",1994,Statistics in Medicine,123,10.1002/sim.4780130906,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-0028273049
Peters J.H.,,Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients,1994,Journal of Thoracic and Cardiovascular Surgery,369,10.1016/S0022-5223(94)70178-4,United States,Article,Los Angeles,1,Journal,2-s2.0-0028027451
Streitz J.M.,,Endoscopic surveillance of Barrett's esophagus: Does it help?,1993,Journal of Thoracic and Cardiovascular Surgery,291,10.1016/s0022-5223(19)34219-9,United States,Article,Burlington,1,Journal,2-s2.0-0027528844
Levine D.S.,,Correlation of Ultrastructural Aberrations With Dysplasia and Flow Cytometric Abnormalities in Barrett's Epithelium,1989,Gastroenterology,35,10.1016/S0016-5085(89)91559-X,United States,Article,Seattle,0,Journal,2-s2.0-0024579577
Prentice R.,,Surrogate endpoints in clinical trials: Definition and operational criteria,1989,Statistics in Medicine,1339,10.1002/sim.4780080407,United States,Article,Seattle,0,Journal,2-s2.0-0024520844
Reid B.,,Observer variation in the diagnosis of dysplasia in Barrett's esophagus,1988,Human Pathology,652,10.1016/S0046-8177(88)80344-7,,Article,,0,Journal,2-s2.0-0023906902
Nowell P.,,The clonal evolution of tumor cell populations,1976,Science,4332,10.1126/science.959840,United States,Article,Philadelphia,0,Journal,2-s2.0-0017167185
Cairns J.,,Mutation selection and the natural history of cancer,1975,Nature,1157,10.1038/255197a0,United Kingdom,Article,London,0,Journal,2-s2.0-0016692602
Naef A.P.,,Columnar lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas,1975,Journal of Thoracic and Cardiovascular Surgery,446,10.1016/s0022-5223(19)39666-7,Switzerland,Article,Yverdon-les-Bains,1,,2-s2.0-0016771074
ALLISON P.,,The oesophagus lined with gastric mucous membrane.,1953,Thorax,306,10.1136/thx.8.2.87,,Article,,1,Journal,2-s2.0-0002067043
Barrett N.,,Chronic peptic ulcerz of the œophagus and ‘œsophagitis’,1950,British Journal of Surgery,629,10.1002/bjs.18003815005,,Article,,0,Journal,2-s2.0-76549218484
